NewsRx

Search our medical news database

Vector Development

Engineered Intrabodies Broaden Research Avenues

Published in Gene Therapy Weekly, October 25th, 1999

Intrabodies designed to recognize sequences of arbitrary immunoglobulins create novel opportunities for bioengineering.

E.C. Ohage and colleagues from the University of Munich, Germany, created intrabodies with gene therapy applications. Their study was reported in the Journal of Molecular Biology ("Intrabody Construction and Expression of A Synthetic Catalytic Fv Fragment," Journal of Molecular Biology, 1999;291(5):1129-1134).

"In general, proteins with structural disulfides cannot be expressed in the reducing environment of the cellular cytoplasm," wrote Ohage et al. "To overcome this folding problem, we have previously engineered stabilizing...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook